ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,990.11
2.51%
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs Yen
155.857
0.02%
Brent Oil
82.915
0.64%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Journey Medical Corporation (DERM)

  7. Journey Medical Corporation (DERM) ニュース

DERM

Journey Medical (DERM)

Journey Medical Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:DERM
日付受信時刻ニュースソース見出しコード企業名
2024/05/0721 : 30GlobeNewswire Inc.Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024NASDAQ:DERMJourney Medical Corporation
2024/05/0205 : 01GlobeNewswire Inc.Journey Medical Corporation Appoints Joseph Benesch as Chief Financial OfficerNASDAQ:DERMJourney Medical Corporation
2024/04/2521 : 30GlobeNewswire Inc.Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024NASDAQ:DERMJourney Medical Corporation
2024/03/2205 : 01GlobeNewswire Inc.Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
2024/03/1821 : 30GlobeNewswire Inc.Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of RosaceaNASDAQ:DERMJourney Medical Corporation
2024/03/1521 : 30GlobeNewswire Inc.Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024NASDAQ:DERMJourney Medical Corporation
2024/03/1321 : 30GlobeNewswire Inc.Journey Medical Corporation to Participate in the 36th Annual ROTH ConferenceNASDAQ:DERMJourney Medical Corporation
2024/03/1121 : 30GlobeNewswire Inc.Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual MeetingNASDAQ:DERMJourney Medical Corporation
2024/02/2407 : 54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DERMJourney Medical Corporation
2024/01/0522 : 30GlobeNewswire Inc.Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat RosaceaNASDAQ:DERMJourney Medical Corporation
2024/01/0306 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
2024/01/0306 : 05GlobeNewswire Inc.Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 MillionNASDAQ:DERMJourney Medical Corporation
2023/12/1606 : 46Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DERMJourney Medical Corporation
2023/12/0907 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
2023/12/0622 : 00GlobeNewswire Inc.Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat RosaceaNASDAQ:DERMJourney Medical Corporation
2023/11/0806 : 45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
2023/11/0806 : 01GlobeNewswire Inc.Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
2023/10/3121 : 30GlobeNewswire Inc.Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:DERMJourney Medical Corporation
2023/10/2021 : 30GlobeNewswire Inc.Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) vs. Solodyn® (Minocycline Hydrochloride Extended-Release Tablets, 105 mg)NASDAQ:DERMJourney Medical Corporation
2023/10/1805 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DERMJourney Medical Corporation
2023/09/2622 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
2023/09/2005 : 59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
2023/09/0902 : 26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DERMJourney Medical Corporation
2023/09/0621 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
2023/09/0621 : 00GlobeNewswire Inc.Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza® in South Korea and Other Asian NationsNASDAQ:DERMJourney Medical Corporation
2023/08/1906 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
2023/08/1505 : 01GlobeNewswire Inc.Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
2023/08/1105 : 45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DERMJourney Medical Corporation
2023/08/0905 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
2023/08/0905 : 01GlobeNewswire Inc.Journey Medical Corporation Reports Second Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
 Showing the most relevant articles for your search:NASDAQ:DERM

最近閲覧した銘柄

PM
XAUUSD
Gold vs US Dollar
NASDAQ
AMZN
Amazon.com
FX
USDGBP
US Dollar vs Sterling
CCOM
US30
US 30
NASDAQ
MSFT
Microsoft
NYSE
MRK
Merck
AMEX
SPY
SPDR S&P 500
NYSE
KO
Coca Cola
USOTC
BASFY
BASF (QX)
USI
USTECH100
US Tech 100
NYSE
DIS
Walt Disney
COIN
SOLUSD
Solana
NYSE
VZ
Verizon Communications
NYSE
JPM
JP Morgan Chase
NASDAQ
TSLA
Tesla
NYSE
BAC
Bank of America
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有